Inova Diagnostics announced the global launch of Quanta-Lyser 3000, a fully automated enzyme linked immunoassay (EIA) and immunofluorescence assay (IFA) processor for use in the clinical laboratory.
Existing methods for EIA and IFA testing used in many laboratories are time- and labor-intensive and prone to transcription errors. Inova said that its processor addresses many shortcomings of manual EIA and IFA processing.
The firm said that its product's 240-capacity sample deck reduces the number of daily interventions, and four independently operating probes provide fast turnaround time. The washable probes eliminate the need for costly disposable tips, the firm said.